A systematic review assessed three small longitudinal studies that enrolled patients screened for LTBI before starting TNF inhibitor in which none of the 29 patients with positive TST/negative IGRA results and none of the 146 patients with negative IGRA results, regardless of TST results, developed active tuberculosis after ≥12 months of follow-up [46]. The gene discussed is TNF; the disease is tuberculosis.